Now showing items 1-1 of 1

  • Development and characterization of biodegradable microspheres containing selected antimycobacterials. 

    Bain, David F. (The Robert Gordon University School of Pharmacy and Life Sciences, 1998-11)
    BAIN, D. F., MUNDAY, D. L. and COX, P. J., 1996. Preparation of rifampicin-loaded biodegradable microspheres. European Journal of Pharmaceutical Sciences, 4, S158
     
    BAIN, D. F., MUNDAY, D. L., COX, P. J. and SMITH, A., 1997. Spray-dried blends of biodegradable polymers to modulate drug release. Journal of Pharmacy and Pharmacology, 49 (Supp. 4), p. 75
     
    BAIN, D. F., MUNDAY, D. L. and SMITH, A., 1998. Mechanisms of rifampicin release from spray-dried blends of biodegradable poly(D,L-lactide) for intra-pulmonary administration. Second World Congress of Pharmaceutics, Biopharmaceutics and Pharmacokinetics, Paris, May 1998.
     
    BAIN, D. F., MUNDAY, D. L. and SMITH, A., 1998. Effect of residual solvent on the characteristics of biodegradable microspheres prepared by spray-drying. Proceedings of the Fifth European Symposium on Controlled Drug Delivery, Leiden, April 1998.
     
    BAIN, D. F., MUNDAY, D. L. and COX, P. J., 1998. Evaluation of biodegradable rifampicin-bearing microsphere formulations using a stability-indicating high-performance liquid chromatography assay. European Journal of Pharmaceutical Sciences, 7, pp. 57-65
     
    BAIN, D. F., MUNDAY, D. L. and SMITH, A., 1999. Modulation of rifampicin release from spray-dried microspheres using combinations of poly(D,L-lactide). Journal of Microencapsulation, 16 (3), pp. 369-385
     
    BAIN, D. F., MUNDAY, D. L. and SMITH, A., 1999. Solvent influence on spray-dried biodegradable microspheres. Journal of Microencapsulation, 16 (4), pp. 453-474
     
    BAIN, D. F., MUNDAY, D. L. and SMITH, A., 1998. Journal of Pharmacy and Pharmacology, 50, p. 161
     
    Prolonged therapy required to effectively treat mycobacterial infection frequently results in severe dose-limiting side-effects and drug resistance due to patient non-compliance with protracted dosage regimens. Biodegradable ...